Leadership Team

Leadership Team

Robert Azelby, MBA
Chief Executive Officer

Mr Azelby has served as our Chief Executive Officer since June 2018.

John A. Latham, Ph.D.
Chief Scientific Officer

Dr. Latham has served as our Chief Scientific Officer since co-founding Alder BioPharmaceuticals in January 2004.

Mark J. Litton, Ph.D., MBA
Chief Business Officer and Treasurer

Dr. Litton has served as our Chief Business Officer, Treasurer and Secretary since co-founding the company in January 2004.

Jeffrey T.L. Smith, M.D., FRCP
Managing Director, Alder BioPharmaceuticals Limited

Dr. Smith has served as Managing Director of Alder BioPharmaceuticals Limited since March 2017.

Elisabeth A. Sandoval, MBA
Chief Commercial Officer and EVP Corporate Strategy

Ms. Sandoval has served as our Chief Commercial Officer since September 2016.

Larry Benedict
Executive Vice President and Principal Accounting Officer

Mr. Benedict joined Alder in 2008 and has served as our Executive Vice President and Principal Accounting Officer since October 2016.

James B. Bucher, J.D.
Senior Vice President and General Counsel

Mr. Bucher has served as our Senior Vice President and General Counsel since January 2016.

Randy Hassler
Senior Vice President, Pharmaceutical Operations

Mr. Hassler has served as our Senior Vice President of Pharmaceutical Operations since August 2014.

Annette Vahratian
Senior Vice President, Quality

Ms. Vahratian has served as our Senior Vice President of Quality since 2017.